2015 Guidance on cancer immunotherapy development in early‐phase clinical studies

The development of cancer immunotherapies is progressing rapidly with a variety of technological approaches. They consist of “cancer vaccines”, which are based on the idea of vaccination, “effector cell therapy”, classified as passive immunotherapy, and “inhibition of immunosuppression”, which inten...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Sci
Main Authors: Arato, Teruyo, Daimon, Takashi, Heike, Yuji, Ishii, Ken, Itho, Kyogo, Kageyama, Shinichi, Kawakami, Yutaka, Nakayama, Eiichi, Ozawa, Keiya, Sato, Noriyuki, Shiku, Hiroshi, Takeuchi, Masahiro, Tani, Kenzaburo, Tamada, Koji, Ueda, Ryuzo, Yamaguchi, Yoshiyuki, Yamanaka, Takeharu, Yamaue, Hiroki, Yasukawa, Masaki, Iguchi, Toyotaka, Kitano, Shigehisa, Miyahara, Yoshihiro, Nagata, Yasuhiro, Noguchi, Masanori, Terashima, Takeshi, Asano, Takeo, Asonuma, Motohiro, Ikeda, Hiroaki, Kakimi, Kazuhiro, Takesako, Kazutoh, Tanaka, Masanori, Amakasu, Kohei, Yamada, Akira, Harada, Naozumi, Aoshi, Taiki, Kuroda, Etsushi, Kobiyama, Kouji, Muraoka, Daisuke, Yamazaki, Naoya, Kuchiba, Aya, Tanaka, Shiro, Michimae, Hirofumi, Yamada, Tomomi, Hanada, Kenichi, Okada, Hideho, Takebe, Naoko, Hirano, Naoto, Okumura, Satoshi, Sato, Daisaku, Shibatsuji, Masayoshi, Yamaguchi, Teruhide
Formato: Artigo
Idioma:Inglês
Publicado em: John Wiley and Sons Inc. 2015
Assuntos:
Report
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4714668/
https://ncbi.nlm.nih.gov/pubmed/26767933
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12819
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados